HALISTER: Pfizer’s Breast Cancer Drug Approved Two Months Early by FDA (2)

Pfizer’s Breast Cancer Drug Approved Two Months Early by FDA (2)

Alert: HALISTER Source: BN (Bloomberg News)

Tickers PFE US (Pfizer Inc) 3400398Z US (HHS Food & Drug Administration)

People Ian Read (Pfizer Inc)

Topics Breast Cancer Cancers Medical, Health Research

To de-activate this alert, run {NLRT DEACT HALISTER <GO>}. To modify this alert, run {NLRT EDIT HALISTER <GO>}.

UUID: 7947283